Less Ads, More Data, More Tools Register for FREE

Pin to quick picksI-nexus Global. Regulatory News (INX)

Share Price Information for I-nexus Global. (INX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.00
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.50 (16.667%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
INX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

26 May 2021 07:00

RNS Number : 7949Z
i-nexus Global PLC
26 May 2021
 

26 May 2021

i-nexus Global plc

("i-nexus", the "Company" or the "Group")

 

Interim Results

 

i-nexus Global plc (AIM: INX), a leading provider of cloud-based Strategy Execution software solutions designed for the Global 5000, today provides its unaudited results for the 6 months ended 31 March 2021.

 

Financial Highlights

· Group Revenue £2.01m (H1 20 £2.27m)

o Recurring revenue £1.81m (H1 20 £2.03m)

o Services revenue £0.20m (H1 20 £0.24m)

· Gross margin increased to 81% (H1 20: 73%)

· Loss before tax £0.43m (H1 20 £2.16m)

· Cash balance at 31 March 2021 £0.81m (Cash and cash equivalents at 30 September 2020: £0.12m)

· Full early repayment of HMRC COVID-19 related deferments

· Exit Monthly Recurring Revenue ("MRR") of £0.29m, impacted by slower than anticipated growth in new business, some mostly expected churn and exchange rate movements - offsetting upsell successes to existing customers

 

Operational Highlights

· Successfully secured £1.325m funding (net of fees) in the form of Fixed rate Unsecured Convertible Redeemable Loan Notes in November 2020

· Existing account upsells were in line with targets, continuing this positive trend

· Multiple live trials of new platform underway with potential customers

· Newly released Gartner Magic Quadrant for Strategic Portfolio Management highlights the growing importance of Strategy Execution Management software and confirms the relevance of our offering

· New business generation continues to be impacted by ongoing budgetary constraints across enterprises, in response to COVID-19

 

Simon Crowther, Chief Executive, of i-nexus Global plc, commented: "While the economic backdrop continues to present us with challenges, the quality and visibility of our revenue, breadth of our customer base and cash position provides us with a secure base. The publication of the Gartner Magic Quadrant for Strategic Portfolio Management confirms the relevance of our solution in the market. We are also encouraged by the number of live customer trials currently underway. Our strategic focus continues to be on growing repeatable, incremental sales, while operating within our financial means. While there will still be challenges ahead, we are confident about the prospects for our chosen market and our capability to meet our customers' business needs."

For further information please contact:

i-nexus Global plc

Simon Crowther, CEO

Alyson Levett, CFO

 

Via: Alma PR 

N+1 Singer (Nominated Adviser and Broker)

Sandy Fraser/Iqra Amin (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

Tel: +44 (0)207 496 3000

Alma PR

Caroline Forde / Robyn Fisher

Tel: +44 (0)203 405 0205

 

About i-nexus Global plc

 

i-nexus Global plc ("i-nexus") provides cloud strategy execution software to leading global brands aspiring to excel at strategy execution. The Group's scalable, enterprise grade platform is deployed within multiple global blue-chip businesses, predominantly based across the US and Europe.

 

By digitalising how companies manage the strategic planning process, from developing robust strategic plans to overseeing their delivery and measuring results for data-driven decision making, i-nexus customers achieve breakthrough performance by delivering more strategic goals at pace.

 

From transformational initiatives across entire organizations to business unit-specific programs, i-nexus strategy execution software is the choice of leaders tasked with aligning people and results to business-critical goals.

 

 

 

 

 

BUSINESS REVIEW

The challenges experienced in the prior financial year continued into the first half of the year, with new business generation impacted by continued enterprise budgetary restrictions. However, our financial planning during the prior year stood us in good stead and we are protecting our cash resources in line with our plan. As we enter June, the business is expected to be operating at an EBITDA break even position with a visible cash runway.

Since the launch of our next generation platform, i-nexus Workbench, we are encouraged by a higher level of interest from new prospects. The flexibility and usability of the platform has enabled us to implement live trials for prospects for the first time, enabling high levels of engagement where prospects can see their own data in the system, providing a powerful proof of the ROI which can be delivered. We currently have live trial implementations at multiple enterprises across the US, UK and Europe. We continue to see an uplift in new business enquiries as a result of our targeted marketing activities but are mindful that the economic backdrop remains challenging.

As with many software companies, we are an agile business and well-equipped to facilitate remote working. Our staff continue to work successfully from home, with no disruption to the Group's continuity of service and indeed some benefits of the greater ease of collaboration. We have therefore decided not to renew the lease on our Coventry HQ. We require a more flexible workspace for the future as lockdown restrictions lift and resource planning can become more definitive.

We continue to develop relationships with potential channel partners, to extend our market reach. Although early days, these relationships are leading to opportunities for the Group with joint marketing initiatives being undertaken.

Market opportunity

We continue to believe that the market opportunity for enterprise level strategy execution software is significant, and the recent publication of the Gartner Magic Quadrant underlines the relevance of our offering in Strategy Execution Management. The cloud and mobile abilities of our products mean they can be used remotely and our platform has increased relevance at a time when organisations are having to make significant strategy adjustments, to course correct for the impacts of COVID-19 on their businesses.

Outlook

While the economic backdrop continues to present us with challenges, the quality and visibility of our revenue, breadth of our customer base and cash position provides us with a secure base. The publication of the Gartner Magic Quadrant for Strategic Portfolio Management confirms the relevance of our solution in the market. We are also encouraged by the number of live customer trials currently underway. Our strategic focus continues to be on growing repeatable, incremental sales, while operating within our financial means. While there will still be challenges ahead, we are confident about the prospects for our chosen market and our capability to meet our customers' business needs.

 

 

FINANCIAL REVIEW

 

Reported revenue

 

Total recognised revenue decreased slightly to £2.01m (H1 20: £2.27m). The Group signed one new customer (H1 20: one) under a recurring contract paid annually in advance.

 

Revenue from recurring contracted software subscriptions reduced by 11% to £1.81m (H1 20: £2.03m), while revenue from associated professional services was relatively stable at £0.20m (H1 20: £0.24m) as both new customer orders and existing client change orders were lower than expected.

 

Monthly Recurring Revenue ("MRR") at the period end was £0.292m (FY 20 £0.305m). Customer churn continues to pose operational challenges and has been exacerbated by COVID-19 as budgets and in some cases, departments running strategy programs, have been cut.

 

Gross margin

Gross margin in the year was 81% (H1 20: 73%) after accounting for commission payable to the Group's business partners. Gross margin has increased as we have reduced certain annual software fees in the light of reduced numbers of users and secured efficiency gains in other areas. Reported gross margin is the blended gross margin over both recurring software subscriptions and professional services.

 

Overheads

Overheads (defined as the aggregate of staff costs and other operating expenses but excluding those costs included in cost of sales) reduced in the period by £1.81m to £1.99m (H1 20: £3.80m) reflecting the full impact of the cost control initiatives undertaken last year.

 

The Board monitors performance carefully against our forecasts and sensitivities are considered. Where these indicate a potential depletion of the Group's cash resources too rapidly, the management team reviews discretionary costs incurred by the Group and the availability of COVID-19 related assistance and takes action as necessary.

 

As a result of the cost control initiatives undertaken, the Group's underlying cost base is running at approximately £300k per month from June 2021, which represents break even at EBITDA level.

 

Capitalised development costs amounted to £0.20m in the period (H1 20 £0.18m), reflecting the ongoing enhancement in our product as planned which we expect to see a return to in the future.

 

The Group's loss before taxation has reduced significantly as a result of last year's cost control exercise to £0.43m (H1 20: £2.16m).

 

 

Cash flow

Cash and cash equivalents closed at £0.81m (H1 20 £0.14m deficit). This was after early repayment of all the HMRC COVID-19 related deferment of approximately £0.45m.

 

Gross debt at 31 March 2021 was £1.59m (H1 20: £0.32m) of which £0.16m was payable within one year, the balance being £0.05m BBLS loan and £1.38m of convertible debt and accrued interest.

 

The Group experienced a net increase in cash and cash equivalents of £0.61m (H1 20 decrease of £1.71m).

 

The Group will continue to apply treasury and foreign currency exposure management policies to minimise both the cost of finance and our exposure to foreign currency exchange rate fluctuations.

 

i-nexus Global plc

Consolidated Statement of Comprehensive Income

 

 

Unaudited Six months ended 31 March 2021

Unaudited Six months ended 31 March 2020

Audited Year ended 30 September 2020

 

 

 

 

£

£

£

Revenue

2,013,472

2,272,934

4,080,582

Cost of Sales

(383,829)

(613,356)

(1,094,342)

Gross Profit

1,629,643

1,659,578

2,986,240

Administrative Expenses

(1,987,403)

(3,795,251)

(5,310,671)

Operating Loss

(357,760)

(2,135,673)

(2,324,431)

Finance Income

5

881

1,007

Financing Costs

(69,001)

(22,410)

(54,299)

Loss before tax

(426,756)

(2,157,202)

(2,377,723)

Tax

197,815

124,635

361,490

Loss for the period/year

(228,941)

(2,032,567)

(2,016,233)

 

 

 

 

Other comprehensive income

 

 

 

Exchange differences arising on translation of foreign operations

86,309

41,367

8,068

Loss on net investment hedge

-

-

(26,307)

Total comprehensive income for the period/year

(142,632)

(1,991,200)

(2,034,472)

 

 

 

 

 

£

£

£

Basic and diluted loss per share

(0.01)

(0.07)

(0.07)

 

 

 

 

Adjusted EBITDA

(134,775)

(2,063,933)

(1,816,412)

Depreciation and profit/loss on disposal

(137,646)

(71,740)

(331,924)

Non-underlying items

(85,339)

-

(176,095)

Operating Loss

(357,760)

(2,135,673)

(2,324,431)

 

 

 

 

Consolidated Statement of Financial Position

 

 

 

Unaudited

Unaudited

Audited

 

As at 31 March

As at 31 March

As at 30 September

 

2021

2020

2020

 

£

£

£

Assets

 

 

 

Non-current assets

 

 

 

Intangible assets

1,321,613

796,771

1,136,808

Property plant and equipment

108,647

284,333

245,963

Total non-current assets

1,430,260

1,081,104

1,382,771

 

 

 

 

Current assets

 

 

 

Trade and other receivables

1,107,449

1,935,612

832,507

Current tax receivable

75,000

63,145

300,000

Cash and cash equivalents

811,768

-

120,011

Total current assets

1,994,217

1,998,757

1,252,518

 

 

 

 

Total assets

3,424,477

3,079,861

2,635,289

 

 

 

 

Current liabilities

 

 

 

Cash and cash equivalents

-

135,821

-

Borrowings

156,513

159,730

179,098

Lease liability

-

-

37,467

Trade and other payables

628,558

895,214

1,239,609

Deferred income

1,998,387

2,292,313

1,723,661

Total current liabilities

2,783,458

3,483,078

3,179,835

 

 

 

 

Non-current liabilities

 

 

 

Borrowings

1,430,208

165,176

64,402

Provisions

30,000

80,702

80,702

Total non-current liabilities

1,460,208

245,878

145,104

Total liabilities

4,243,666

3,593,135

3,324,939

Net liabilities

(819,189)

(649,095)

(689,650)

 

 

 

 

Equity

 

 

 

Share capital

2,957,161

2,957,161

2,957,161

Share premium

7,256,188

7,256,188

7,256,188

Capital redemption reserve

-

-

-

Share based payment reserve

13,093

-

-

Foreign exchange reserve

70,839

17,829

(15,470)

Merger reserve

10,653,881

10,653,881

10,653,881

Accumulated losses

(21,770,351)

(21,534,154)

(21,541,410)

Total Equity

(819,189)

(649,095)

(689,650)

 

 

 

Consolidated Statement of Cash Flow

 

 

Unaudited

Unaudited

Audited

 

As at 31 March

As at 31 March

As at 30 September

 

2021

2020

2020

 

£

£

£

Cash flows from operating activities

 

 

 

Loss after taxation

(228,941)

(2,032,566)

(2,002,316)

Tax expense

(197,815)

(124,635)

(361,485)

Loss before taxation

(426,756)

(2,157,202)

(2,377,723)

 

 

 

 

Adjustments for non-cash/non-operating items

 

 

 

Depreciation and profit on disposal

137,646

71,740

331,924

Amortisation & impairment of intangible

16,520

-

-

Share based payment

13,093

-

-

Finance income

(5)

(881)

(1,007)

Finance charges

69,001

22,410

54,299

 

(190,501)

(2,063,933)

(1,992,507)

 

 

 

 

Changes in working capital:

 

 

 

(Increase)/Decrease in trade and other receivables

(274,942)

(180,464)

690,536

(Increase/Decrease) in provisions

(50,702)

-

-

(Increase/Decrease) in trade and other payables

(336,324)

704,208

489,077

Taxation

422,815

124,635

361,490

Net cash from operating activities

(429,654)

(1,415,554)

(451,404)

 

 

 

 

Cash flows from investing activities

 

 

 

Purchase of property, plant and equipment

(330)

(16,942)

(39,744)

Purchase of development costs

(201,325)

(178,162)

(628,210)

Interest received

5

881

1,007

Net cashflow from investing activities

(201,650)

(194,223)

(666,947)

 

 

 

 

Cash flows from financing activities

 

 

 

Principle elements of lease costs

(37,467)

-

(89,000)

Funds raised

 

 

 

Proceeds from borrowings

1,375,000

-

-

Repayment of borrowings

(86,988)

(78,324)

(159,730)

Interest paid

(13,793)

(22,410)

(54,299)

Net cash flow from financing activities

1,236,752

(100,734)

(303,029)

 

 

 

 

Net increase in cash and cash equivalents

605,448

(1,710,511)

(1,421,380)

Cash and cash equivalents beginning of the period

120,011

1,533,323

1,533,323

Effect of foreign exchange rate changes

86,309

41,367

8,068

Cash and cash equivalents at the end of the period

811,768

(135,821)

120,011

 

 

 

 

 

Consolidated Statement of Changes in Equity

 

 

 

 

 

Capital

Share Based

Foreign

 

 

 

 

 

Issued

Share

Redemption

Payment

exchange

Merger

Accumulated

Total

 

 

Capital

Premium

Reserve

Reserve

reserve

reserve

losses

Equity

 

 

£

£

£

£

£

£

£

£

HY FY2020

Unaudited

 

 

 

 

 

 

 

 

As at 1 October 2019

2,957,161

7,256,188

-

-

(23,538)

10,653,881

(19,501,587)

1,342,105

Loss for period

-

-

-

-

-

-

(2,032,567)

(2,032,567)

Other comprehensive income for the period

-

-

-

-

41,367

-

-

41,367

Share based payment

-

-

-

-

-

-

-

-

As at 31 March 2020

2,957,161

7,256,188

-

-

17,829

10,653,881

(21,534,154)

(649,095)

FY2020

Audited

 

 

 

 

 

 

 

 

As at 1 October 2019

2,957,161

7,256,188

-

-

(23,538)

10,653,881

(19,501,587)

1,342,105

Loss for period

-

-

-

-

-

-

(2,016,233)

(2,016,233)

Loss on investment hedge

-

-

-

-

-

-

(26,307)

(26,307)

Transition to IFRS 16

-

-

-

-

-

-

2,717

2,717

 

 

 

 

 

 

 

 

 

Exchange differences on foreign operations

-

-

-

-

8,068

-

-

8,068

As at 30 September 2020

2,957,161

7,256,188

-

-

(15,470)

10,653,881

(21,541,410)

(689,650)

HY FY2021

Unaudited

 

 

 

 

 

 

 

 

As at 1 October 2020

2,957,161

7,256,188

-

-

(15,470)

10,653,881

(21,541,410)

(689,650)

Loss for period

-

-

-

-

-

-

(228,941)

(228,941)

Exchange differences on foreign operations

-

-

-

-

86,309

-

-

86,309

Share based payment

-

-

-

13,093

-

-

-

13,093

As at 30 March 2021

2,957,161

7,256,188

-

13,093

70,839

10,653,881

(21,770,351)

(819,189)

 

Notes to the consolidated interim report

For the six months ended 31 March 2021

1. General information

i-nexus Global plc (the "Company") is a public limited company domiciled in the UK and incorporated in England and Wales (registered number 11321642) and its registered office is George House, Herald Avenue, Coventry Business Park, Coventry CV5 6UB.

The principal activity of i-nexus Global plc ("the Company") and its subsidiary company i-solutions Global Limited (together "i-nexus Global" or "the Group") is the development and sale of Enterprise Cloud based software and associated professional Consultancy services. 

The interim condensed consolidated financial statements were approved for issue on 26 May 2021.

2. Basis of preparation

This unaudited interim condensed consolidated financial information has been prepared under the historical cost convention and in accordance with AIM Rules for Companies. The interim condensed consolidated financial information has been prepared on a going concern basis and is presented in Sterling to the nearest £1.

In line with guidance and the ongoing impact of the COVID-19 Pandemic management continues to assess forecasts to determine the going concern basis.

Forecasts are adjusted for reasonable sensitivities that address the principal risks and uncertainties to which the Group is exposed, thus creating a number of different scenarios for the Board to challenge. The Board has derived a cost mitigation plan for the scenarios modelled as part of the going concern review. On the basis of this analysis, the Board has concluded that there is a reasonable expectation that the Group will have adequate resources to continue in operational existence for the foreseeable future being a period of at least twelve months from the balance sheet date.

The accounting policies used in the preparation of the interim condensed consolidated financial information are consistent with those set out in the 2020 Annual Report and Accounts. The Group will continue to review its accounting policies in the light of emerging industry consensus on the practical application of IFRS.

The preparation of financial information in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial information and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the events or actions involved, actual outturns ultimately may differ from those estimates. The interim information does not include all financial risk management information and disclosures required in annual financial statements; the information should be read in conjunction with the financial information, as at 30 September 2020, summarised in the 2020 Annual Report and Accounts. Section 6 below summarises the most relevant of these.

The interim condensed consolidated financial information for the six months ended 31 March 2021 and for the six months ended 31 March 2020 do not constitute statutory accounts as defined in Section 434 of the Companies Act 2006 and are unaudited. The financial information for the six months ended 31 March 2021 presents financial information for the consolidated group, including the financial results of the Company's wholly owned subsidiary, i-solutions Global Limited. Comparative figures in the Interim Report for the year ending 30 September 2020 have been taken from the Group's audited financial statements on which the Group's auditors, Saffery Champness LLP, expressed an unqualified opinion.

 3. Segmental reporting

The Directors consider that there is one identifiable business segment that is engaged in providing individual products or services or a group of related products and services that comprise the core business.

 All of the Group's assets and operations are located in the UK and the USA.

4. Loss per share

The calculation of basic and diluted loss per share for the six months to 31 March 2021 was based upon the loss attributable to ordinary shareholders of £228,941 (six months to 31 March 2020: £2,032,567, year ended 30 September 2020: £2,016,233) and a weighted average number of ordinary shares in issue of 29,571,610 (six months to 31 March 2020: 29,571,610, year ended 30 September 2020: 29,571,610), calculated as follows:

Weighted average number of ordinary shares

 

Six months

Six months

Year

 

ended

ended

ended

 

31 March

31 March

30 September

 

2021

2020

2020

Loss for the period attributable to equity holders of the Company

(228,941)

(2,032,567)

(2,016,233)

Issued ordinary shares at start of period/year

29,571,610

29,571,610

29,571,610

Weighted average number of shares at end of period/year

29,571,610

29,571,610

29,571,610

Loss per share

0.01

0.07

0.07

5. Availability of Interim Report

Electronic copies of this Interim Report will be available on the Group's website at www.i-nexus.com.

6. Principle risks and uncertainties

Although the directors seek to minimise the impact of risk factors, the Group is subject to a number of such factors. Those most relevant to our performance in H2 are as follows:

Working capital

 

Whilst the Directors believe that the injection of funds, from the convertible bond issue on 4th November 2020, has provided flexibility to satisfy the Group's near-term funding requirements, there can be no guarantee as to the Group's longer term working capital requirements and, therefore, the Group may need to seek additional capital over and above that raised from the issue of the Convertible Loan Notes. No assurance can be given as to the availability of such additional capital at any future time or, the terms upon which such additional capital would be available.

 

The Group's continuing viability in the longer term remains dependent on its ability to secure new sales to existing and potential customers. Given the nature of the COVID-19 Pandemic, it is not possible to know the potential impact of the ongoing crisis on the activities of the Group for the remainder of the financial year and beyond and, in particular, it is possible that as a direct or indirect result the Group will continue to experience a slower and/or lower sales conversion rate than the Directors have modelled within their central case financial projections. This could in turn have a material adverse effect on the Group's business, results of operations, financial condition and prospects.

 

Covid 19 impact

 

The COVID-19 Pandemic has affected the performance of the business of the Group. As at the date of this document, given the nature of the crisis, the Group is not aware of the full extent of the effects of the COVID-19 Pandemic for the remainder of the financial year or beyond.

Whilst the Group continues to monitor the situation on a regular basis and may be able to introduce further cost saving measures if needed, it is possible that in the longer term the COVID-19 Pandemic will have a material adverse effect on the Group's business, results of operations, financial condition and prospects. Also, there is no assurance that the implementation of the Group's strategic and operational changes introduced to date will be successful under current or future market conditions. Furthermore, if there were to be further outbreaks of the COVID-19 Pandemic either globally or in the Group's markets this could materially adversely affect the Group's business, results, financial condition and prospects.

 

Customer churn

The Group has experienced falling revenues in relation to certain customers in the past and in H1. The reasons for this are varied and our historical ability to invest in our customers was limited. While our investment in customer retention activities is seeing benefits, customer churn is still a risk for the Group and could affect the Group's trading and financial position and prospects.

Implementation of Growth Strategy

 

Failure to successfully implement its growth strategies. The Board recognises that executing the Group's strategy may be difficult to implement/achieve and may not be as successful as planned. Pressure on management, limitations on operational and financial resources, the potential insufficiency of demand for the Group's products and a slower than anticipated market acceptance of the Group's products could lead to failure to successfully implement its strategies and so adversely affect the Group's reputation, prospects, results of operations, and its financial condition.

 

Digitalising Strategy Execution

 

Failure of the market to accept the need/urgency to digitalise their Strategy Execution. A large proportion of the Group's target market continues to use traditional methods and in-house developed systems to assist in their SE. The Board believes the market needs further education in the benefits of digitalising SE. Potential customers may prefer to "do nothing" and be unnecessarily cautious about investing in the Group's software. Failure by the Group to adequately explain the value proposition to increase the market's readiness to accept the technology will lead to slower than projected growth.

 

Account Proliferation

 

Failure of our existing accounts to grow, resulting from dissatisfaction with the product and/or deployment issues. An important aspect of the Group's growth strategy is to proliferate sales of its i-nexus software with existing customers as a result of the natural evolution of the software use over time. Although the Group has a number of examples where this has occurred in the past, this is no guarantee that it will continue to happen at the increasing rate predicted. Any failure of this anticipated account proliferation to happen will affect the Group's future success and adversely affect its business, prospects and results of operations and financial position. 

 

7. Forward-looking statements

This announcement may include certain forward-looking statements, beliefs or opinions, including statements with respect to the Group's business, financial condition and results of operations. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "anticipates", "targets", "aims", "continues", "expects", "intends", "hopes", "may", "will", "would", "could" or "should" or, in each case, their negative or other various or comparable terminology. These statements are made by the Directors in good faith based on the information available to them at the date of this announcement and reflect the Directors' beliefs and expectations. By their nature these statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. A number of factors could cause actual results and developments to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, developments in the global economy, changes in government policies, spending and procurement methodologies, and failure in health, safety or environmental policies. No representation or warranty is made that any of these statements or forecasts will come to pass or that any forecast results will be achieved. Forward-looking statements speak only as at the date of this announcement and the Group and its advisers expressly disclaim any obligations or undertaking to release any update of, or revisions to, any forward-looking statements in this announcement. No statement in the announcement is intended to be, or intended to be construed as, a profit forecast or to be interpreted to mean that earnings per share for the current or future financial years will necessarily match or exceed the historical earnings. As a result, you are cautioned not to place any undue reliance on such forward-looking statements.

8. Statement of Directors' Responsibilities

 The Directors confirm to the best of their knowledge that:

 i) The condensed interim financial information has been prepared in accordance with IAS 34 as adopted by the European Union; and

 ii) The interim management report includes a fair review of the information required by the FCA's Disclosure and Transparency Rules (4.2.7 R and 4.2.8 R).

Financial statements are published on the Group's website in accordance with legislation in the United Kingdom governing the preparation and dissemination of financial statements, which may vary from legislation in other jurisdictions. The maintenance and integrity of the Group's website is the responsibility of the Directors. The Directors' responsibility also extends to the ongoing integrity of the financial statements contained therein.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR SEFFWIEFSESI
12
Date   Source Headline
26th Feb 20245:54 pmRNSResult of AGM
26th Feb 20247:00 amRNSAGM Statement
4th Jan 20245:53 pmRNSHolding(s) in Company
20th Dec 20237:00 amRNSFinal Results
17th Oct 20237:00 amRNSCustomer Update
7th Jul 202312:34 pmRNSResult of General Meeting
21st Jun 20237:00 amRNSProposed issue of up to £0.5 million
28th Apr 20237:00 amRNSInterim Results
3rd Mar 20239:28 amRNSHolding(s) in Company
27th Feb 202311:46 amRNSResult of AGM and current trading update
20th Dec 20227:00 amRNSFinal Results
11th Nov 20222:11 pmRNSGrant of LTIP options
3rd Oct 20221:31 pmRNSGrant of LTIP options
30th Sep 20223:12 pmRNSConvertible Loan Notes Redemption Date Extension 
2nd Aug 20228:00 amRNSFurther re Board Change
30th May 20227:00 amRNSInterim Results
24th May 20224:40 pmRNSSecond Price Monitoring Extn
24th May 20224:35 pmRNSPrice Monitoring Extension
12th May 20229:54 amRNSHolding(s) in Company
6th May 20222:00 pmRNSPrice Monitoring Extension
5th May 20227:00 amRNSAppointment of CFO
28th Apr 202212:20 pmRNSHolding(s) in Company
22nd Apr 20221:52 pmRNSHolding(s) in Company
28th Feb 202212:25 pmRNSResult of AGM and Trading Update
21st Dec 20217:00 amRNSFinal Results
29th Sep 202111:10 amRNSResult of General Meeting
13th Sep 20217:00 amRNSProposed issue of up to £0.65 million
2nd Sep 20212:41 pmRNSUpdate on trading and financial position
16th Jun 20214:41 pmRNSSecond Price Monitoring Extn
16th Jun 20214:35 pmRNSPrice Monitoring Extension
26th May 20217:00 amRNSInterim Results
18th May 20214:41 pmRNSSecond Price Monitoring Extn
18th May 20214:35 pmRNSPrice Monitoring Extension
18th May 20212:05 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:35 pmRNSPrice Monitoring Extension
22nd Apr 20212:06 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:01 pmRNSPrice Monitoring Extension
20th Apr 20219:05 amRNSSecond Price Monitoring Extn
20th Apr 20219:00 amRNSPrice Monitoring Extension
20th Apr 20217:00 amRNSHolding(s) in Company
20th Apr 20217:00 amRNSStatement re Share Price Movement
19th Apr 20214:40 pmRNSSecond Price Monitoring Extn
19th Apr 20214:35 pmRNSPrice Monitoring Extension
19th Apr 20212:00 pmRNSPrice Monitoring Extension
16th Apr 20219:05 amRNSSecond Price Monitoring Extn
16th Apr 20219:00 amRNSPrice Monitoring Extension
29th Mar 20213:14 pmRNSDirector/PDMR Shareholding
25th Mar 20214:18 pmRNSResult of AGM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.